MIRA INFORM REPORT

 

 

Report Date :

09.04.2012

 

IDENTIFICATION DETAILS

 

Name :

CONCORD BIOTECH LIMITED

 

 

Registered Office :

1482-86, Trasad Road, Dholka, Ahmedabad-387810, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

23.11.1984

 

 

Com. Reg. No.:

04-007440

 

 

Capital Investment / Paid-up Capital :

Rs.46.026 Millions

 

 

CIN No.:

[Company Identification No.]

U24230GJ1984PLC007440

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMC00391G

 

 

PAN No.:

[Permanent Account No.]

AAACC8514G

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Penicilin G Amidase.

 

 

No. of Employees :

450 (Approximately)

 

RATING & COMMENTS

 

MIRA’s Rating :

A ( 64)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 4450000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having fine track. Trade relations are fair. Business is active. General financial position is good. Payments are reported as usually correct and as per commitments.

 

The company can be considered good for normal business dealings.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INFORMATION PARTED BY

 

Name :

Mr. Vishal

Designation :

Finance Department

Contact No.:

91-79-26937681

 

 

LOCATIONS

 

Registered Office/ Works :

1482-86, Trasad Road, Dholka, Ahmedabad-387810, Gujarat, India

Tel. No.:

91-2714-222604/ 221904

Fax No.:

91-2714-222504

E-Mail :

finance@concordbiotech.com

purchase@concordbiotech.com

projects@concordbitotech.com

sales@concordbiotech.com

finance@concordbiotech.com

Website :

http://www.concordbiotech.com

 

 

Head Office :

302, Sakar III, Opposite Old Gujarat High Court, Off ITO Circle, Ahmedabad-380014, Gujarat, India

Tel. No.:

91-79-27544998

Fax No.:

91-79-27540802

E-Mail :

concord@concordbiotech.com

 

 

Corporate Office :

B – 1002, Safal Pegasus, 10th Floor, Near Prahladnagar Garden, 100ft Road, Satellite Road, Ahmedabad – 380015, Gujarat, India

Tel. No.:

91-79-40321179

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Sudhir Jairam Vaid

Designation :

Managing Director

Address :

99, Basant Bahar, Opposite Sterling City, Bopal, Ahmedabad – 380058, Gujarat, India

Date of Birth/Age :

03.09.1952

Date of Appointment :

10.05.2000

DIN No.:

00055967

Other Directorship:

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230GJ1984PLC007440

CONCORD BIOTECH LIMITED

Managing director

14/02/2011

10/05/2000

-

Active

NO

2

U74140GJ2004PTC043545

SUDMAN CONSULTANTS PRIVATE LIMITED

Director

2/08/2005

2/08/2005

-

Active

NO

 

 

Name :

Mr. Ravi Narendranath Kapoor

Designation :

Director

Address :

202, Pravesh 10, Mahadev Nagar Society, Sardar Patel Road, Ahmedabad – 380014, Gujarat, India

Date of Birth/Age :

25.07.1963

Date of Appointment :

15.12.2003

DIN No.:

00003847

Other Directorship:

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24229GJ1987PTC009600

RENI CONSULTANTS PRIVATE LIMITED

Director

11/07/2000

11/07/2000

-

Active

NO

2

U24230GJ1984PLC007440

CONCORD BIOTECH LIMITED

Director

15/12/2003

15/12/2003

-

Active

NO

3

U74140GJ2004PTC044545

AMITY CONSULTANTS PRIVATE LIMITED

Director

20/12/2004

20/12/2004

-

Active

NO

4

U74999GJ1991PTC016402

YAN ADVISORY SERVICES PRIVATE LIMITED

Director

5/02/2007

5/02/2007

-

Active

NO

5

U74140GJ2006PLC048053

CORPORATE STRATEGIC ALLIANZ LIMITED

Director

1/04/2007

1/04/2007

-

Active

NO

6

U45202GJ2007PLC049808

SADBHAV INFRASTRUCTURE PROJECT LIMITED

Director

30/09/2008

1/04/2008

-

Active

NO

7

U29224GJ1987PLC010044

JOHN ENERGY LIMITED

Director

30/09/2009

27/02/2009

-

Active

NO

8

U74900GJ2008PTC053973

CORONEY TECHNOLOGIES PRIVATE LIMITED

Additional director

15/02/2012

15/02/2012

-

Active

NO

 

 

Name :

Mr. Ankur Sudhir Vaid

Designation :

Whole Time Director

Address :

99, Basant Bahar, Opposite Sterling City, Bhopal, Ahmedabad – 380058, Gujarat, India

Date of Birth/Age :

14.04.1982

Date of Appointment :

04.12.2009

DIN No.:

01857225

Other Directorship:

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U74140GJ2004PTC043545

SUDMAN CONSULTANTS PRIVATE LIMITED

Director

26/04/2007

26/04/2007

-

Active

NO

2

U24230GJ1984PLC007440

CONCORD BIOTECH LIMITED

Whole-time director

1/09/2011

4/12/2009

-

Active

NO

 

 

Name :

Mr. Utpal Hemendra Sheth

Designation :

Director

Address :

B -27, Kum Kum Apartment, S.V. Road, Near Nanavati Hospital, Vile Parle, Mumbai – 400056, Maharashtra, India

Date of Birth/Age :

20.06.1971

Date of Appointment :

04.12.2009

DIN No.:

00081012

Other Directorship:

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U65990MH1991PTC063580

INSIGHT ASSET MANAGEMENT (INDIA) PRIVATE LIMITED

Director

11/10/1991

11/10/1991

-

Active

NO

2

U67120MH1997PTC105571

HRS INSIGHT FINANCIAL INTERMEDIARIES PRIVATE LIMITED

Director

31/01/1997

31/01/1997

-

Active

NO

3

U67100MH2005PTC151400

CHANAKYA CORPORATE SERVICES PRIVATE LIMITED

Director

18/02/2005

18/02/2005

-

Active

NO

4

U51900MH1998PTC116557

TRUST TRADE AND INVESTMENT COMPANY PRIVATE LIMITED

Director

19/10/2006

19/10/2006

-

Strike off

NO

5

L72900MH2000PLC123841

APTECH LIMITED

Director

28/10/2006

28/10/2006

-

Active

NO

6

U19200MH1977PLC019449

METRO SHOES LIMITED

Alternate director

14/03/2007

14/03/2007

-

Active

NO

7

L27101PN1985PLC038031

PRAJ INDUSTRIES LIMITED

Director appointed in casual vacancy

28/07/2007

28/07/2007

-

Active

NO

8

U65910MH1986PTC040671

CLUE LEASING AND FINANCE PRIVATE LIMITED

Director

1/11/2007

1/11/2007

-

Active

NO

9

U17120MH1993PTC074456

RARE EQUITY PRIVATE LIMITED

Additional director

1/11/2007

1/11/2007

-

Active

NO

10

U67120MH1988PTC049423

HILLCROFT INVESTMENTS COMPANY PRIVATE LIMITED

Additional director

1/11/2007

1/11/2007

-

Active

NO

11

U45400MH2008PTC177950

MOSS PROPERTIES PRIVATE LIMITED

Director

11/02/2008

11/02/2008

-

Strike off

NO

12

U45400MH2008PTC177951

MOSS ESTATES PRIVATE LIMITED

Director

11/02/2008

11/02/2008

-

Strike off

NO

13

U24110MH2001PLC134105

INNOVASSYNTH TECHNOLOGIES (INDIA) LIMITED

Director

30/09/2009

25/06/2008

-

Active

NO

14

L72200AP1993PLC015939

ZEN TECHNOLOGIES LIMITED

Director

12/09/2008

30/06/2008

-

Active

NO

15

U74920MH1982PLC027283

TOPS SECURITY LIMITED

Director

15/12/2008

22/07/2008

-

Active

NO

16

U70102MH2008PTC183684

RACE AHEAD PROPERTIES PRIVATE LIMITED

Director

20/08/2008

20/08/2008

-

Active

NO

17

L72200AP1990PLC011146

NCC LIMITED

Alternate director

31/10/2009

31/10/2009

-

Active

NO

18

U24230GJ1984PLC007440

CONCORD BIOTECH LIMITED

Director

14/09/2010

4/12/2009

-

Active

NO

19

L92142MH2002PLC135964

CINEMAX INDIA LIMITED

Additional director

29/10/2010

28/07/2010

-

Active

NO

20

U65991MH2010PTC206150

TRUST-PLUTUS WEALTH MANAGERS (INDIA) PRIVATE LIMITED

Director

31/07/2010

31/07/2010

-

Active

NO

21

U34300MH1994PLC081463

KLT AUTOMOTIVE AND TUBULAR PRODUCTS LIMITED

Director

29/09/2011

25/09/2010

-

Active

NO

22

U67110MH2011PTC215357

TRUST CAPITAL HOLDINGS PRIVATE LIMITED

Director

26/03/2011

26/03/2011

-

Active

NO

23

L92490TN1986PLC013044

STERLING HOLIDAY RESORTS (INDIA) LIMITED

Additional director

8/03/2012

7/11/2011

-

Active

NO

 

 

Name :

Mr. Harcharan Mohan Singh

Designation :

Director

Address :

10, Waterloo Crt, Thornhill, On – L3T6L9

Date of Birth/Age :

19.05.1949

Date of Appointment :

04.12.2009

DIN No.:

02852915

Other Directorship:

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24230GJ1984PLC007440

CONCORD BIOTECH LIMITED

Director

14/09/2010

4/12/2009

-

Active

NO

2

U51101AP2010PTC071300

GLOPEC INTERNATIONAL (INDIA) PRIVATE LIMITED

Director

22/11/2010

22/11/2010

-

Active

NO

 

 

Name :

Mr. Rajiv Ambrish Agarwal

Designation :

Director

Address :

Chamaria Niwas, 3rd Floor, 41, Mahant Road, Vile Parle (E), Mumbai – 400057, Maharashtra, India

Date of Birth/Age :

28.03.1971

Date of Appointment :

30.06.2008

DIN No.:

00379990

Other Directorship:

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U85110AP1992PLC014728

QUALITY CARE INDIA LIMITED

Director

27/12/2005

27/12/2005

30/03/2012

Active

NO

2

U74999PN2006PTC128787

AVALON AVIATION ACADEMY PRIVATE LIMITED

Director

20/07/2006

20/07/2006

1/04/2011

Active

NO

3

L72900MH2000PLC123841

APTECH LIMITED

Director

28/06/2007

29/10/2006

-

Active

NO

4

L55101AP1965PLC001048

VICEROY HOTELS LIMITED

Alternate director

31/01/2007

31/01/2007

-

Active

NO

5

U29224GJ1987PLC010044

JOHN ENERGY LIMITED

Director

30/09/2008

8/05/2008

-

Active

NO

6

U24230GJ1984PLC007440

CONCORD BIOTECH LIMITED

Director

30/09/2009

30/06/2008

-

Active

NO

7

U12000MH1999PTC119259

HUNGAMA DIGITAL MEDIA ENTERTAINMENT PRIVATE LIMITED

Director

25/09/2008

1/09/2008

-

Active

NO

8

U65910MH2007PTC172599

EQUIRUS CAPITAL PRIVATE LIMITED

Director

10/08/2010

10/08/2010

-

Active

NO

9

U74120MH2011PTC224699

HUNGAMA DIGITAL SERVICES PRIVATE LIMITED

Director

8/12/2011

8/12/2011

-

Active

NO

10

U74999MH2012PTC226152

HUNGAMA .COM PRIVATE LIMITED

Director

17/01/2012

17/01/2012

-

Active

NO

 

 

Name :

Mr. Satish Khanna

Designation :

Director

Address :

Flat No.71/A/71B, Royal Accord III, Lokhandwala Complex, Andheri (West), Mumbai – 400058, Maharashtra, India

Date of Birth/Age :

07.10.1953

Date of Appointment :

07.05.2011

DIN No.:

01827559

Other Directorship :

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U74140MH2005PTC153578

VALMAX CORPORATE SERVICES PRIVATE LIMITED

Director

27/05/2005

27/05/2005

-

Active

NO

2

U24231GJ2006PLC047462

NOVODIGM LIMITED

Director

14/08/2008

26/09/2007

-

Amalgamated

NO

3

U24230GJ1984PLC007440

CONCORD BIOTECH LIMITED

Director

30/09/2011

7/05/2011

-

Active

NO

4

U24232MH2010PTC199429

FULLIFE HEALTHCARE PRIVATE LIMITED

Director

22/07/2011

15/07/2011

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Prakash Sajnani

Designation :

Secretary

Address :

Flat No.6, 2nd Floor, Suryarath Flats B/H, Jhangiram Hospital, Kubernagar, Ahmedabad – 382340, Gujarat, India

Date of Birth/Age :

05.06.1971

Date of Appointment :

15.02.2004

PAN No.:

AHHPS5622G

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

Sudhir Vaid and Manju Vaid

 

1374842

Ankur Vaid

 

30160

Megha Vaid

 

28364

Sudman Consultants Private Limited, India

 

432000

Rakesh Junhjunhwala

 

784898

Hemang Raichand Dharamshi and Harsha Hemang Dharamshi

 

13970

Ravindra Raichand Dharmashi

 

119294

Amal Niranjan Parikh

 

119580

Ravi Kapoor

 

20000

Tripat Kanta Vaid

 

10000

Jhunjhunwala Rekha Rakesh

 

616332

Amit Goel

 

5726

Rajeshkumar Radheshyam Junhjunhwala

 

22908

Prembala Singh

 

110590

Colvyn James Harris

 

4000

Abhigam Shares and Securities Private Limited, India

 

57274

Rajiv Agarwal

 

11454

 

 

Equity Share Break up (Percentage of Total Equity)

As on 30.09.2011

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

5.57

Bodies corporate

10.63

Directors or relatives of Directors

42.10

Other top fifty shareholders

41.70

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Penicilin G Amidase.

 

 

Products :

PRODUCT DESCRIPTION

ITC CODE NO.

Mycophenolate Mofetil

2942.00.90

Tacrolimus

2942.00.90

Sirolimus

2942.00.90

 

PRODUCTION STATUS AS ON 31.03.2011

 

Particulars

Unit

 

Installed Capacity

Actual Production

Biotechnology

MT

 

15.00

9.863

Bulk Drugs

MT

 

119.00

32.596

 

 

GENERAL INFORMATION

 

No. of Employees :

450 (Approximately)

 

 

Bankers :

Axis Bank Limited, Trishul, 3rd Floor, Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad-3800006, Gujarat, India

 

 

Facilities :

Secured Loan

As on 31.03.2011

(Rs. in Millions)

As on 31.03.2010

(Rs. in Millions)

Rupee term loans banks secured

7.581

22.710

Other debt secured

15.447

0.000

Total

23.028

22.710

Note:

(A) Secured by Equitable mortgage of the Land and Building except corporate office. First charge over plant and machinery and equipments situated at Dholka Factory and extension of charge over the entire current assets of the Company. [Payable within 12 Months Rs.7.581 Millions (Previous Year Rs.15.000 Millions)]

(B) Secured by Equitable mortgage of the Land and Building except corporate office. First charge over plant and machinery and equipments situated at Dholka Factory and extension of charge over the entire current assets of the Company. [Payable within 12 Months Rs.7.581 Millions (Previous Year Rs.15.000 Millions)]

(C) Buyers Credit Limit: (Exclusive first charge over the entire fixed assets of the Company (Both present and future) excluding vehicles and  corporate office extension of charge over the entire current assets of the company)

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Deloitte Haskins and Sells

Chartered Accountants

Address :

Heritage, 3rd Floor, Near Gujarat, Vidhyapith, off Ashram Road, Ahmedabad-380014, Gujarat, India

PAN.:

AABFD7919A

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

6000000

Equity Shares

Rs.10/- each

Rs.60.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

4602596

Equity Shares

Rs.10/- each

Rs.46.026 Millions

 

 

 

 

 

Of the above shares 2301298 Equity shares (Previous Year NIL) of Rs.10 each were issued as fully Paid up Bonus shares by capitalisation of Securities Premium During the financial year 2009-10 the Company has bought back and extinguished 232237 equity shares pursuant to provisions of Section 77A & 77B of the Companies Act 1956.

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

46.026

23.012

25.335

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

1065.960

749.837

623.397

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

1111.986

772.849

648.732

LOAN FUNDS

 

 

 

1] Secured Loans

23.028

22.710

72.269

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

23.028

22.710

72.269

DEFERRED TAX LIABILITIES

71.830

36.280

27.806

 

 

 

 

TOTAL

1206.844

831.839

748.807

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

639.379

404.169

329.909

Capital work-in-progress

70.489

120.418

64.403

 

 

 

 

INVESTMENT

0.000

30.092

120.335

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

187.487
140.438

149.873

 

Sundry Debtors

301.750
238.174

109.145

 

Cash & Bank Balances

122.287
6.111

2.270

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

80.282
55.465

33.367

Total Current Assets

691.806
440.188

294.655

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

84.111
83.501

40.994

 

Other Current Liabilities

48.217
15.450

12.196

 

Provisions

62.502
64.077

7.305

Total Current Liabilities

194.830
163.028

60.495

Net Current Assets

496.976
277.160

234.160

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

1206.844

831.839

748.807

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

1085.885

1046.996

531.307

 

 

Other Income

38.068

17.695

28.933

 

 

TOTAL                                     (A)

1123.953

1064.691

560.240

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption materials changes inventories

177.899

212.598

 

 

Manufacturing service costs

185.292

133.472

367.655

 

 

Employee related expenses

62.182

41.568

 

 

 

Administrative selling other expenses

57.724

52.644

 

 

 

Research development expenditure

16.595

7.970

 

 

 

TOTAL                                     (B)

499.692

448.252

367.655

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

624.261

616.439

192.585

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

1.723

3.830

6.799

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

622.538

612.609

185.786

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

69.773

50.983

43.648

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

552.765

561.626

142.138

 

 

 

 

 

Less

TAX                                                                  (H)

159.958

192.000

46.459

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

392.807

369.626

95.679

 

 

 

 

 

Add

PRIOR PERIOD ADJUSTMENTS

--

--

1.251

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

568.136

278.276

181.346

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

37.000

0.000

 

 

Dividend

93.670

34.520

0.000

 

 

Tax on Dividend

 

5.866

0.000

 

 

Employee Benefits

 

0.000

0.000

 

BALANCE CARRIED TO THE B/S

867.273

568.136

278.276

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

462.260

611.126

314.038

 

TOTAL EARNINGS

462.260

611.126

314.038

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

22.945

27.811

7.934

 

 

Stores & Spares

2.767

0.008

0.373

 

 

Capital Goods

42.971

37.394

29.027

 

TOTAL IMPORTS

68.683

65.213

37.334

 

 

 

 

 

 

Earnings Per Share (Rs.)

85.34

79.79

40.14

 

Expected Sales (2011-2012): Rs. More than 1300.000 Millions

 

The above information has been parted by Mr. Vishal (Finance Department)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

34.94
34.72

17.07

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

50.90
53.64

26.75

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

41.52
66.52

22.75

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.50
0.73

0.21

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.20
0.24

0.20

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

3.55
2.70

4.87

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes/ No)

Year of Establishment

Yes

Locality of the firm

Yes

Constitutions of the firm

Yes

Premises details

No

Type of Business

Yes

Line of Business

Yes

Promoter’s Background

Yes

No. of Employees

Yes

Name of person Contacted

Yes

Designation of contact person

Yes

Turnover of firm for last three years

Yes

Profitability for last three years

Yes

Reasons for Variation <> 20%`

--

Estimation for coming financial year

Yes

Capital in the business

Yes

Details of sister concern

No

Major Suppliers

No

Major Customers

No

Payment Terms

Yes

Export/ Import Details (If applicable)

No

Market Information

--

Litigations that the firm/ Promoter involved in

--

Banking Details

Yes

Banking Facility details

Yes

Conduct of the banking account

--

Buyer visit details

--

Financials, if provided

Yes

Incorporation details, if applicable

Yes

Last accounts filed at ROC

Yes

Major Shareholders , if available

Yes

 

Operations:

 

Company continues to focus on technology development and improvement and considering the fact the same is not possible without proper Research & Development infrastructure it has during the year set up an state of art R&D facility by incurring a capital cost of Rs.83.780 Millions. This will help Company substantially in the time to come.

 

Company would consolidate its operations further during the current year and are hopeful of increase in revenues as compared to the performance.

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U24230GJ1984PLC007440

Name of the company

CONCORD BIOTECH LIMITED

Address of the registered office or of the principal place of  business in India of the company

1482-86, Trasad Road, Dholka, Ahmedabad – 387810, Gujarat, India

Email : finance@concordbiotech.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

90099613

Type of charge

Book Debts

Movable Property

Particular of charge holder

Axis Bank Limited, Trishul 3rd Floor Opp Samartheshwar Temple, Law Garden, Ellisbridge, Ahmedabad -380006, Gujarat, India

Email : Deepak3.Sharma@axisbank.com

Nature of instrument creating charge

Supplement Deed of Hypothecation

Date of instrument Creating the charge

17.02.2012

Amount secured by the charge

Rs.140.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Extent and Operation of the charge

Charge of Rs.140.000 Millions on Primary security Exclusive first charge on entire current assets of the Co.(both present and future)Collateral Security: Extension of Charge on the entire movable fixed assets of the Company (both present and future) excluding vehicles. Extension of charge on immovable fixed assets of the Company (both present and future) situated at RS.no.1482-1486, Dholka, District Ahmedabad, excluding a.) all other immovable properties in the name of the Company b.)machinery purchased under buyer credit limit availed by Citi Bank

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Exclusive first charge on the entire current assets of the Company both present and future.

Extension of charge over the entire moveable fixed assets of the Company (both present and future) excluding vehicles.

Extension of charge over immovable fixed asset of the Company (both present and future) situated / installed at Survey No. 1482-1486 Dholka, District Ahmedabad excluding

a) all other immovable properties in the name of the Company

b) machinery purchased under Buyer's credit limit availed from Citi Bank

Date of instrument modifying the charge

17.02.2012

Particulars of the present modification

By this modification the Bank has enhanced limit of Bank Guarantee from Rs.150.000 Millions to 20.000 Millions and Letter of Credit from Rs. 10.000 Millions to 20.000 Millions and the overall limit of this charge is increased from Rs. 111.500 Millions to Rs. 140.000 Millions. The entire break of the facilities granted are mentioned below: (Rs. in Millions)

CC: 80.000 Millions, WCDL:(50.000 Millions), Inland LCBD:(30.000 Millions), EPC/ PCFC/ FBP/ FBD/ PSCFC:(80.000 Millions), B G:20.000 Millions, LC:20.000 Millions Buyers Credit as sub limit of CC:(50.000 Millions) LER: (40.000 Millions) LER (On stand alone basis): 20.000 Millions

 

FIXED ASSETS

 

Tangible Assets

  • Land
  • Building
  • Plant and Machinery
  • Laboratory Equipments
  • Office Equipments
  • Furniture and Fixture
  • Computer
  • Vehicles

 

In Tangible Assets

  • Software
  • Technical Know - how

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.05

UK Pound

1

Rs.81.09

Euro

1

Rs.67.39

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

8

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

64

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.